Nanobiotix SA 65th ASTRO Annual Meeting 2023 Transcript
Good day and thank you for standing by. Welcome to the Nanobiotix Study 102 program update conference call. (Operator Instructions) Please be advised that today's conference is being recorded. At this point, I'll turn the call over to Craig West, Senior Vice President, Investor Relations, of Nanobiotix.
Thank you, operator, and moving to slide 2.
Good afternoon and good morning. And welcome to the Nanobiotix conference call to discuss the final results of our Phase 1 102 study in locally advanced head and neck cancer. Joining me on the call today are Laurent Levy, Co-Founder and Chief Executive Officer; and Bart Van Rhijn, Chief Financial Officer. As a reminder, today's call is being webcast and will be available on our website for replay.
I would like to remind you that this call will include forward-looking statements, which may include statements regarding the progress, success, and timing of our ongoing and planned clinical trials, collaborations, regulatory filings, dates of presentations, and future
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
